
Twist Bioscience (TWST) had the highest return between January 1, 2026 and October 31, 2026 by a mid-cap US stock, returning 381.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Twist Bioscience (TWST) | 1/1/2026 - 10/31/2026 | 381.5% |
CareDx (CDNA) | 1/1/2026 - 10/31/2026 | 363.96% |
10X Genomics (TXG) | 1/1/2026 - 10/31/2026 | 329.86% |
Veradermics (MANE) | 1/1/2026 - 10/31/2026 | 310.85% |
Immunitybio (IBRX) | 1/1/2026 - 10/31/2026 | 310.4% |
Erasca (ERAS) | 1/1/2026 - 10/31/2026 | 286.79% |
MaxLinear (MXL) | 1/1/2026 - 10/31/2026 | 278.41% |
Pulse Biosciences (PLSE) | 1/1/2026 - 10/31/2026 | 277.73% |
Okeanis Eco Tankers (ECO) | 1/1/2026 - 10/31/2026 | 259.9% |
Abcellera Biologics (ABCL) | 1/1/2026 - 10/31/2026 | 258.77% |
Kodiak Sciences (KOD) | 1/1/2026 - 10/31/2026 | 255.36% |
AXT (AXTI) | 1/1/2026 - 10/31/2026 | 220.12% |
Oruka Therapeutics (ORKA) | 1/1/2026 - 10/31/2026 | 219.6% |
Hyperliquid Strategies Inc Common Stock (PURR) | 1/1/2026 - 10/31/2026 | 211.9% |
Iovance Biotherapeutics (IOVA) | 1/1/2026 - 10/31/2026 | 205.04% |
Spyre Therapeutics (SYRE) | 1/1/2026 - 10/31/2026 | 194.75% |
PBF Energy (PBF) | 1/1/2026 - 10/31/2026 | 190.68% |
Enliven Therapeutics (ELVN) | 1/1/2026 - 10/31/2026 | 185.48% |
Ringcentral (RNG) | 1/1/2026 - 10/31/2026 | 182.36% |
Definium Therapeutics (DFTX) | 1/1/2026 - 10/31/2026 | 169.11% |
International Seaways (INSW) | 1/1/2026 - 10/31/2026 | 166.28% |
Sasol (SSL) | 1/1/2026 - 10/31/2026 | 164.92% |
Penguin Solutions (PENG) | 1/1/2026 - 10/31/2026 | 161.22% |
Iridium Communications (IRDM) | 1/1/2026 - 10/31/2026 | 159.55% |
Tango Therapeutics (TNGX) | 1/1/2026 - 10/31/2026 | 156.72% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.